L'accès aux traitements antisida en Afrique : une analyse de la stratégie de brevet des entreprises multinationales

According to Attaran and Gillespie-White (2001), there is no link between patents and poor access to HIV/AIDS treatments in Africa since multinationals patent a few. Questioning what the authors call the rule and the exceptions, this paper shows that multinationals use patents as entry barriers towards southern generics producers, which impedes access to medicines and hinders the industrial development of these generics producers.

MoreLess

Year of publication:	2005
Authors:	Guennif, Samira ; Mfuka, Claude
Published in:	Mondes en développement. - De Boeck Université. - Vol. 131.2005, 3, p. 75-86
Publisher:	De Boeck Université
Subject:	patent \| strategy \| multinationals \| Africa \| generics producers \| antiretrovirals

More details

Extent:	application/pdf text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10005237303